|
US20020164350A1
(en)
|
1992-09-03 |
2002-11-07 |
Lowy Douglas R. |
Chimeric papillomavirus-like particles
|
|
US5618536A
(en)
*
|
1992-09-03 |
1997-04-08 |
The United States Of America As Represented By The Department Of Health And Human Services |
Chimeric papillomavirus-like particles
|
|
US8062642B1
(en)
|
1993-03-09 |
2011-11-22 |
University Of Rochester |
Production of papillomavirus capsid protein and virus-like particles
|
|
US20020039584A1
(en)
|
1998-02-20 |
2002-04-04 |
Medigene Ag |
Papilloma virus capsomere vaccine formulations and methods of use
|
|
GB9806666D0
(en)
*
|
1998-03-27 |
1998-05-27 |
Stanley Margaret |
Antigen preparation and use
|
|
TR200102423T2
(tr)
|
1998-12-04 |
2002-02-21 |
Biogen, Inc. |
Peptid ligandları yoluyla bağlı birden fazla imünojenik bileşeni olan HBV çekirdek antijeni parçacıkları
|
|
SE514982C2
(sv)
|
1999-09-30 |
2001-05-28 |
Active Biotech Ab |
Bärare innehållande ett huvudkapsidprotein L1 från humant papillomavirus samt dess användning
|
|
CN1114690C
(zh)
*
|
2001-05-15 |
2003-07-16 |
乔良 |
乳头瘤假病毒及其制备方法
|
|
US20040121465A1
(en)
*
|
2002-02-14 |
2004-06-24 |
Novavax, Inc. |
Optimization of gene sequences of virus-like particles for expression in insect cells
|
|
US9045727B2
(en)
|
2002-05-17 |
2015-06-02 |
Emory University |
Virus-like particles, methods of preparation, and immunogenic compositions
|
|
GB2392158B
(en)
*
|
2002-08-21 |
2005-02-16 |
Proimmune Ltd |
Chimeric MHC protein and oligomer thereof
|
|
KR20050114225A
(ko)
|
2003-03-07 |
2005-12-05 |
머크 앤드 캄파니 인코포레이티드 |
인플루엔자 바이러스 백신
|
|
WO2004101598A2
(en)
|
2003-05-09 |
2004-11-25 |
Research Development Foundation |
Insertion of furin protease cleavage sites in membrane proteins and uses thereof
|
|
CN101193654A
(zh)
|
2005-06-14 |
2008-06-04 |
赛托斯生物技术公司 |
抗原偶联物及其用途
|
|
US20070160628A1
(en)
|
2005-08-31 |
2007-07-12 |
Birkett Ashley J |
Stabilized virus-like particles and epitope display systems
|
|
US20070104689A1
(en)
|
2005-09-27 |
2007-05-10 |
Merck Patent Gmbh |
Compositions and methods for treating tumors presenting survivin antigens
|
|
MX2008007292A
(es)
|
2005-12-08 |
2008-10-17 |
Univ Louisville Res Found |
Composiciones inmunoestimuladoras y metodos.
|
|
WO2008082719A2
(en)
*
|
2006-08-30 |
2008-07-10 |
University Of Rochester |
Combined human papillomavirus vlp/gene delivery system and use thereof as a vaccine for prophylaxis and immunotherapy of infectious diseases and tumors
|
|
WO2008121461A2
(en)
*
|
2007-02-26 |
2008-10-09 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Vaccine for activating helper function of cd8+ tcells
|
|
PT2145189E
(pt)
|
2007-05-08 |
2016-06-16 |
Us Health |
Pseudovírus de papilomavírus para deteção e terapêutica de tumores
|
|
US8088392B2
(en)
|
2007-06-18 |
2012-01-03 |
Yunxu Cao |
Capsid proteins and uses therefore
|
|
EP2217699A4
(en)
*
|
2007-10-22 |
2012-11-28 |
Univ Rochester |
RESPIRATORY SYNCYTIAL VIRUS VACCINE BASED ON CHIMERIC PAPILLOMAVIRUS-SIMILAR PARTICLES OR CAPSOMERS
|
|
WO2009092113A2
(en)
|
2008-01-19 |
2009-07-23 |
Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods and compositions for the delivery of vaccines to disrupted epithelium
|
|
BRPI0915076A2
(pt)
|
2008-06-09 |
2017-03-14 |
Bharat Biotech Int Ltd |
composições de vacina, composição imunogênica, método para expressão dos antígenos quiméricos de hpv-hbsag supramencionados, composição farmacêutica, método para ocasionar resposta de anticorpo protetor para composição antigênica e/ou resposta de célula t citotóxica, uso das formulações antigênicas supramencionadas.
|
|
CN107080833A
(zh)
|
2009-04-10 |
2017-08-22 |
约翰·霍普金斯大学 |
作为广谱人类乳头状瘤病毒（hpv）疫苗的乳头状瘤病毒样颗粒（vlp）
|
|
CN107252489A
(zh)
|
2009-04-13 |
2017-10-17 |
法国健康和医学研究院 |
Hpv颗粒及其用途
|
|
US20120052088A1
(en)
|
2009-04-30 |
2012-03-01 |
Coley Pharmaceutical Group, Inc. |
Pneumococcal vaccine and uses thereof
|
|
US9580474B2
(en)
|
2010-09-08 |
2017-02-28 |
The Johns Hopkins University |
Polyionic papilloma virus-like particle (VLP) vaccines
|
|
CN102153656B
(zh)
*
|
2011-01-12 |
2014-11-19 |
广州市元通医药科技有限公司 |
一种嵌合病毒样颗粒疫苗及其制备方法
|
|
CN103561771B
(zh)
|
2011-03-17 |
2019-01-04 |
伯明翰大学 |
重新定向的免疫治疗
|
|
KR20140050698A
(ko)
|
2011-07-29 |
2014-04-29 |
셀렉타 바이오사이언시즈, 인크. |
체액성 및 세포독성 t 림프구(ctl) 면역 반응을 발생시키는 합성 나노운반체
|
|
US9771397B2
(en)
|
2011-12-01 |
2017-09-26 |
University Of Cape Town |
HPV chimaeric particle
|
|
WO2013119877A1
(en)
|
2012-02-07 |
2013-08-15 |
Aura Biosciences, Inc. |
Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells
|
|
US9561275B2
(en)
|
2012-09-14 |
2017-02-07 |
The Johns Hopkins University |
Compositions and methods for rendering tumor cells susceptible to CD8+ T cell-mediated killing
|
|
CA2942654A1
(en)
|
2013-03-15 |
2014-09-18 |
Bullet Biotechnology, Inc. |
Specific multivalent virus-like particle vaccines and uses thereof
|
|
EP3046583B1
(en)
|
2013-09-18 |
2019-02-13 |
Aura Biosciences, Inc. |
Virus-like particle conjugates for treatment of tumors
|
|
ES2738582T3
(es)
|
2014-02-14 |
2020-01-23 |
Immune Design Corp |
Inmunoterapia del cáncer a través de combinación de inmunoestimulación local y sistémica
|
|
WO2015196112A1
(en)
|
2014-06-19 |
2015-12-23 |
The Regents Of The University Of Colorado, A Body Corporate |
Human papilloma virus constructs
|
|
WO2016112921A1
(en)
*
|
2015-01-15 |
2016-07-21 |
University Of Copenhagen |
Virus-like particle with efficient epitope display
|
|
ES2727552T3
(es)
|
2015-02-18 |
2019-10-17 |
Hoffmann La Roche |
Inmunoconjugados para la inducción específica de la citotoxicidad de los linfocitos T frente a una célula diana
|
|
US11213577B2
(en)
|
2015-04-28 |
2022-01-04 |
Albert Einstein College Of Medicine, Inc. |
Treatment of cancer using recall antigens delivered by attenuated bacteria
|
|
WO2017020570A1
(en)
|
2015-08-06 |
2017-02-09 |
Medigen Biotechnology Corp. |
Virus-like particle vaccines
|
|
WO2017075615A1
(en)
*
|
2015-10-29 |
2017-05-04 |
Bullet Biotechnology, Inc. |
Virus-like particle intermediates, agents attached thereto, methods for making and uses thereof
|
|
EP3368068B1
(en)
|
2015-10-30 |
2020-11-18 |
University of Copenhagen |
Virus like particle with efficient epitope display
|
|
WO2017075399A1
(en)
|
2015-10-30 |
2017-05-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Targeted cancer therapy
|
|
JP2018532801A
(ja)
|
2015-10-30 |
2018-11-08 |
ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
標的化がん療法
|
|
EP3370755B1
(en)
|
2015-11-06 |
2021-09-29 |
Regents of the University of Minnesota |
Activation of resident memory t cells for cancer immunotherapy
|
|
FI3377103T4
(fi)
|
2015-11-19 |
2025-04-16 |
Revitope Limited |
Funktionaalinen vasta-ainefragmenttikomplementointi kaksikomponenttiselle järjestelmälle epätoivottujen solujen uudelleenohjattua tappamista varten
|
|
WO2017112830A1
(en)
|
2015-12-21 |
2017-06-29 |
La Jolla Institute For Allergy And Immunology |
Leveraging immune memory from common childhood vaccines to fight disease
|
|
WO2017112797A1
(en)
|
2015-12-22 |
2017-06-29 |
Thomas Jefferson University |
Intra-lesional cmv-based cancer vaccines
|
|
GB201603625D0
(en)
*
|
2016-03-02 |
2016-04-13 |
Glaxosmithkline Biolog Sa |
Novel influenza antigens
|
|
WO2017177204A1
(en)
|
2016-04-09 |
2017-10-12 |
La Jolla Institute For Allergy And Immunology |
Leveraging immune memory from common childhood vaccines to fight disease
|
|
WO2018106972A1
(en)
|
2016-12-07 |
2018-06-14 |
La Jolla Institute For Allergy And Immunology |
Compositions for cancer treatment and methods and uses for cancer treatment and prognosis
|
|
US11197890B2
(en)
|
2016-12-12 |
2021-12-14 |
New York Society For The Relief Of The Ruptured And Crippled, Maintaining The Hospital For Special Surgery |
Methods of treating cancer, infectious disease, and autoimmune disease using CXC chemokines
|
|
JP2020524710A
(ja)
*
|
2017-06-23 |
2020-08-20 |
パソヴァックス エルエルシー |
免疫応答の抗原特異的リダイレクターとしてのキメラウイルス様粒子およびその使用
|
|
EP3661550A4
(en)
|
2017-08-03 |
2021-08-04 |
Regents of the University of Minnesota |
ACTIVATION OF LYMPHOCYTES T MEMORY RESIDENTS FOR THE TREATMENT OF CANCER
|
|
KR20250044945A
(ko)
|
2017-11-06 |
2025-04-01 |
더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 |
기존의 미생물 면역을 활용한 암 치료
|
|
WO2020017962A1
(en)
|
2018-07-16 |
2020-01-23 |
Dcprime B.V. |
A combination product for use in tumor vaccination.
|
|
DE102018123327A1
(de)
*
|
2018-09-21 |
2020-03-26 |
Christian Uhlik |
Modulares Raumluft-Behandlungssystem
|
|
AU2019414934A1
(en)
*
|
2018-12-27 |
2021-06-24 |
Verimmune Llc |
Conjugated virus-like particles and uses thereof as anti-tumor immune redirectors
|
|
AU2020248407C1
(en)
|
2019-03-26 |
2025-12-04 |
Aura Biosciences, Inc. |
Human papillomavirus nanoparticle formulations
|
|
CA3195963A1
(en)
*
|
2020-10-19 |
2022-04-28 |
Joshua Weiyuan WANG |
Virus-inspired compositions and methods of redirecting preexisting immune responses using the same for treatment of cancer
|